Leica BOND MSH6 Mode D'emploi page 50

Bibliography
1. Clinical Laboratory Improvement Amendments of 1988, Final Rule 57 FR 7163 February 28, 1992.
2. Villanova PA. National Committee for Clinical Laboratory Standards (NCCLS). Protection of laboratory workers from infectious
diseases transmitted by blood and tissue; proposed guideline. 1991; 7(9). Order code M29-P.
3. Bancroft JD and Stevens A. Theory and Practice of Histological Techniques. 4th Edition. Churchill Livingstone, New York. 1996.
4. Offit K. MSH6 Mutations in Hereditary Nonpolyposis Colon Cancer: Another Slice of the Pie. Journal of Clinical Oncology. 2004;
22: 4449-4451.
5. Shia J, et al. Value of Immunohistochemical Detection of DNA Mismatch Repair Proteins in Predicting Germline Mutation in
Hereditary Colorectal Neoplasms. The American Journal of Surgical Pathology. 2005; 29: 96-104.
6. Shia J, et al. Immunohistochemistry as First-line Screening for Detecting Colorectal Cancer Patients at Risk for Hereditary
Nonpolyposis Colorectal Cancer Syndrome: A 2-antibody Panel May be as Predictive as a 4-antibody Panel. The American Journal
of Surgical Pathology. 2009; 33: 1639-1645.
7. Berends MJ, et al. Molecular and Clinical Characteristics of MSH6 Variants: An Analysis of 25 Index Carriers of a Germline Variant.
The American Journal of Human Genetics. 2002; 70: 26-37.
8. Caldes T, et al. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers
in hereditary non-polyposis colorectal cancer. Oncology Reports. 2004; 12: 621-629.
9. Kets CM, et al. Unfavorable pathological characteristics in familial colorectal cancer with low-level microsatellite instability. Modern
Pathology. 2006; 19: 1624-1630.
Дата выпуска
21 Январь 2019 г.
PA0990
Page 49